Olanzapine Injection, Powder, For Solution
Product Images NDC 67184-0573

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 67184-0573). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Image 01)

Chemical Structure (Image 01)
Chemical structure of olanzapine showing its molecular framework including fused aromatic rings and a thiazepine ring with nitrogen, sulfur atoms, and attached methyl groups.*
FDA Label Image

Container Label (OLANZAPINE FOR INJECTION 10 mg/vial)

Container Label (OLANZAPINE FOR INJECTION 10 mg/vial)
Label for Olanzapine for Injection 10 mg/vial, a sterile single-dose vial for intramuscular use by Qilu Pharmaceutical Co., Ltd. The label includes usage instructions to see accompanying literature and space for lot and expiry dates. It also features the NDC 67184-0573 with dosage form as powder for solution.*
FDA Label Image

Carton Label (OLANZAPINE FOR INJECTION 10 mg/vial)

Carton Label (OLANZAPINE FOR INJECTION 10 mg/vial)
Olanzapine 10 mg/vial injection powder for solution packaging label by Qilu Pharmaceutical Co., Ltd. The label indicates a sterile single-dose vial for intramuscular use only. It includes storage instructions, inactive ingredients, and dosing guidance upon reconstitution. The NDC 67184-0573 is printed alongside a barcode and manufacturer information from Jinan, China.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.